Quercetin Modulates the p53 Signaling Pathway to Induce Apoptosis: Combating Vemurafenib Resistance in Melanoma
Journal of Clinical Pharmacy and Therapeutics · 2025-01 · 2025 (1)
DOI: 10.1155/jcpt/2635281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 04.08.2025. Verfasst von Ching Wen Huang und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shin Kong Wu Ho-Su Memorial Hospital.
Abstract (Originalsprache)
Background
Melanoma is an aggressive skin cancer with a high potential for developing resistance to targeted therapies. One such therapy, vemurafenib, specifically inhibits the B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) V600E mutation, a key driver of melanoma progression. However, acquired resistance to vemurafenib remains a major challenge, necessitating alternative treatment strategies. Quercetin, a natural flavonoid with well‐documented anticancer properties, has demonstrated potential in overcoming drug resistance, making it a promising candidate for melanoma therapy. Materials and Methods: This study evaluated the effects of quercetin on both melanoma A375.S2 and vemurafenib‐resistant A375.S2/VR cells. Cell viability was assessed using the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay, while apoptosis was measured through caspase‐3/‐7 activity and terminal deoxynucleotidyl transferase dUTP nick‐end labeling (TUNEL) assay. Ribonucleic acid (RNA) sequencing and Ingenuity Pathway Analysis (IPA) were employed to identify the mechanisms underlying quercetin’s effects.
Results
Quercetin significantly reduced cell viability in a dose‐dependent manner in both cell lines, with A375.S2/VR cells requiring higher concentrations, while HaCaT cells, a normal keratinocyte cell line, remained unaffected, accompanied by an increase in apoptotic cell numbers and caspase‐3/‐7 activity. RNA sequencing revealed 379 differentially expressed genes, with IPA indicating significant involvement of the p53 signaling pathway. Increased caspase‐3/‐7 activity and apoptotic cell numbers confirmed apoptosis induction. Key regulators and pathways involved in apoptosis and inflammation were identified.
Conclusions
Quercetin effectively induces apoptosis in vemurafenib‐resistant melanoma cells by modulating the p53 signaling pathway, presenting a promising therapeutic strategy for overcoming drug resistance. Furthermore, in vivo studies are needed to validate these findings and explore clinical applications.
Förderung
- Shin Kong Wu Ho-Su Memorial Hospital
Zitieren
APA
Huang, C. W., Chu, G. Y., Huang, C. C., & Hsu, C. H. (2025). Quercetin Modulates the p53 Signaling Pathway to Induce Apoptosis: Combating Vemurafenib Resistance in Melanoma. Journal of Clinical Pharmacy and Therapeutics, 2025(1). https://doi.org/10.1155/jcpt/2635281
Vancouver
Huang CW, Chu GY, Huang CC, Hsu CH. Quercetin Modulates the p53 Signaling Pathway to Induce Apoptosis: Combating Vemurafenib Resistance in Melanoma. Journal of Clinical Pharmacy and Therapeutics. 2025;2025(1). doi:10.1155/jcpt/2635281
BibTeX
@article{Huang2025,
author = {Huang, Ching Wen and Chu, Gong Yau and Huang, Chieh Chen and Hsu, Chung Hua},
title = {Quercetin Modulates the p53 Signaling Pathway to Induce Apoptosis: Combating Vemurafenib Resistance in Melanoma},
journal = {Journal of Clinical Pharmacy and Therapeutics},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/jcpt/2635281}
}
EUVIMED